0001209191-23-022421.txt : 20230403
0001209191-23-022421.hdr.sgml : 20230403
20230403200013
ACCESSION NUMBER: 0001209191-23-022421
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230403
DATE AS OF CHANGE: 20230403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Puttagunta Sailaja
CENTRAL INDEX KEY: 0001792314
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38503
FILM NUMBER: 23794668
MAIL ADDRESS:
STREET 1: C/O BIOMX LTD.
STREET 2: 7 PINHAS SAPIR ST., FLOOR 2
CITY: NESS ZIONA
STATE: L3
ZIP: 7414002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Iterum Therapeutics plc
CENTRAL INDEX KEY: 0001659323
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: FITZWILLIAM COURT, 1ST FLOOR
STREET 2: LEESON CLOSE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 YW24
BUSINESS PHONE: (872) 225-6077
MAIL ADDRESS:
STREET 1: FITZWILLIAM COURT, 1ST FLOOR
STREET 2: LEESON CLOSE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 YW24
FORMER COMPANY:
FORMER CONFORMED NAME: Iterum Therapeutics Ltd
DATE OF NAME CHANGE: 20151124
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-31
0
0001659323
Iterum Therapeutics plc
ITRM
0001792314
Puttagunta Sailaja
C/O ITERUM THERAPEUTICS PLC
FITZWILLIAM COURT, FL. 1, LEESON CLOSE
DUBLIN 2
L2
IRELAND
0
1
0
0
Chief Medical Officer
0
Stock Option (Right to Buy)
1.00
2023-03-31
4
A
0
75000
0.00
A
2033-03-30
Ordinary Shares
75000
75000
D
The shares underlying this option shall vest at a rate of 33.3% of the total number of shares on the one-year anniversary of March 31, 2023 and the remaining 66.7% will vest in equal monthly installments thereafter until March 31, 2026, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date.
/s/ Sailaja Puttagunta
2023-04-03